Brainlab’s ExacTrac® System Achieves Major Sales Milestone

Munich, January 11, 2012 – Today Brainlab announced the 500th sale of its ExacTrac® patient positioning system for frameless radiosurgery. The scale of uptake highlights physicians continued focus on adopting clinically proven systems for high-precision cancer treatments and their ongoing investment in ensuring access to advanced radiation therapy for patients.

The ExacTrac® system, first developed almost a decade ago, has been proven consistent and reliable in supporting accurate frameless radiosurgery for patients with tumors of the brain, spine and beyond. The system has since been internationally recognized as offering high accuracy, flexibility and increased patient comfort during treatment.

ExacTrac® works by combining with advanced radiosurgery treatment systems to allow physicians to treat cancers using a frameless radiosurgery technique. This offers a valuable alternative to the historical practice that requires immobilization with an invasive head ring affixed to the skull. The advanced image guidance and computer-driven optimization of ExacTrac® enables physicians to control every step of the treatment pathway, improving workflow and flexibility of treatment planning.

Samuel Ryu, M.D., Director of Radiation Oncology at the Henry Ford Health System, USA, comments on the evolution of cancer treatment to frameless radiosurgery:

'We have transitioned to frameless radiosurgery after conducting thorough scientific verifications of the precision of the technique. We have now widely adopted the technique and are applying protocols to treat more than 99 percent of our patients frameless.'

source: Brainlab